GB0416397D0 - Pharmaceutical formulations - Google Patents

Pharmaceutical formulations

Info

Publication number
GB0416397D0
GB0416397D0 GB0416397A GB0416397A GB0416397D0 GB 0416397 D0 GB0416397 D0 GB 0416397D0 GB 0416397 A GB0416397 A GB 0416397A GB 0416397 A GB0416397 A GB 0416397A GB 0416397 D0 GB0416397 D0 GB 0416397D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical formulations
formulations
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0416397A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB0416397A priority Critical patent/GB0416397D0/en
Publication of GB0416397D0 publication Critical patent/GB0416397D0/en
Priority to PCT/EP2005/007991 priority patent/WO2006008173A2/en
Ceased legal-status Critical Current

Links

GB0416397A 2004-07-22 2004-07-22 Pharmaceutical formulations Ceased GB0416397D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0416397A GB0416397D0 (en) 2004-07-22 2004-07-22 Pharmaceutical formulations
PCT/EP2005/007991 WO2006008173A2 (en) 2004-07-22 2005-07-20 Pharmaceutical formulations for inhalation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0416397A GB0416397D0 (en) 2004-07-22 2004-07-22 Pharmaceutical formulations

Publications (1)

Publication Number Publication Date
GB0416397D0 true GB0416397D0 (en) 2004-08-25

Family

ID=32922634

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0416397A Ceased GB0416397D0 (en) 2004-07-22 2004-07-22 Pharmaceutical formulations

Country Status (2)

Country Link
GB (1) GB0416397D0 (en)
WO (1) WO2006008173A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0601951D0 (en) 2006-01-31 2006-03-15 Novartis Ag Organic compounds
CA2667543A1 (en) * 2006-10-26 2008-05-02 Boehringer Ingelheim International Gmbh New pharmaceutical combinations for treatment of respiratory and gastrointestinal disorders
EP1921070A1 (en) 2006-11-10 2008-05-14 Boehringer Ingelheim Pharma GmbH & Co. KG Bicyclic heterocycles, medicaments comprising them, their use and process for their preparation
AU2009203693B2 (en) 2008-01-11 2012-06-07 Novartis Ag Pyrimidines as kinase inhibitors
DK2245026T3 (en) 2008-02-07 2012-10-15 Boehringer Ingelheim Int Spirocyclic heterocycles, drug containing these compounds, their use and process for their preparation
US8648191B2 (en) 2008-08-08 2014-02-11 Boehringer Ingelheim International Gmbh Cyclohexyloxy substituted heterocycles, pharmaceutical compositions containing these compounds and processes for preparing them
JP5809985B2 (en) 2009-02-26 2015-11-11 グラクソ グループ リミテッドＧｌａｘｏ Ｇｒｏｕｐ Ｌｉｍｉｔｅｄ A medicament comprising 4-{(1R) -2-[(6- {2-[(2,6-dichlorobenzyl) oxy] ethoxy} hexyl) amino] -1-hydroxyethyl} -2- (hydroxymethyl) phenol Formulation
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
WO2012034095A1 (en) 2010-09-09 2012-03-15 Irm Llc Compounds and compositions as trk inhibitors
UY33597A (en) 2010-09-09 2012-04-30 Irm Llc COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF THE TRK
KR20140014184A (en) 2011-02-25 2014-02-05 아이알엠 엘엘씨 Compounds and compositions as trk inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1229075B (en) * 1985-04-05 1991-07-17 Fidia Farmaceutici Topical compsn. contg. hyaluronic acid deriv. as vehicle
JPH1180032A (en) * 1997-09-12 1999-03-23 Dai Ichi Seiyaku Co Ltd Composite
DE10064219B9 (en) * 2000-12-22 2009-02-12 Nasalis Pain Relief International Gmbh Novel pharmaceutical composition containing fentanyl and / or its derivatives
US7060691B2 (en) * 2002-10-10 2006-06-13 Giuseppe Petrigni Pharmaceutical colloidal preparation useful in the treatment of respiratory diseases

Also Published As

Publication number Publication date
WO2006008173A2 (en) 2006-01-26
WO2006008173A3 (en) 2006-05-26

Similar Documents

Publication Publication Date Title
IL177566A0 (en) Pharmaceutical formulations
GB0426301D0 (en) Pharmaceutical formulations
IL223545A0 (en) Pharmaceutical compositions
ZA200700030B (en) Pharmaceutical compositions
GB0408308D0 (en) Pharmaceutical compositions
IL172824A0 (en) Pharmaceutical formulations
GB0302671D0 (en) Pharmaceutical formulations
PL1837019T3 (en) Orally-dispersible pharmaceutical compositions
EP1805154A4 (en) Pharmaceutical compositions
GB0302672D0 (en) Pharmaceutical formulations
GB0416397D0 (en) Pharmaceutical formulations
GB0423800D0 (en) New pharmaceutical formulations
HK1105358A1 (en) Solid pharmaceutical formulation
GB0316341D0 (en) Pharmaceutical formulations
GB0406048D0 (en) Drug formulations
EP1716865A4 (en) Paraoxonase-containing pharmaceutical preparation
EP1747205A4 (en) Pharmaceutical compositions
GB0502792D0 (en) Pharmaceutical compositions
GB0411502D0 (en) Pharmaceutical compositions
GB0400971D0 (en) Pharmaceutical compositions
GB0407351D0 (en) Pharmaceutical compositions
GB0428010D0 (en) Pharmaceutical formulations
GB0408076D0 (en) Pharmaceutical formulations
GB0408070D0 (en) Pharmaceutical formulations
GB0316335D0 (en) Pharmaceutical formulations

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)